Blar i NTNU Open på forfatter "Linnet, Kristjan"
-
Association between prescription of hypnotics/anxiolytics and mortality in multimorbid and non-multimorbid patients: a longitudinal cohort study in primary care.
Linnet, Kristjan; Sigurdsson, Johann Agust; Tomasdottir, Margret Olafia; Sigurdsson, Emil Larus; Gudmundsson, Lárus S (Journal article; Peer reviewed, 2019)ObjectivesTo assess the risk of mortality in primary care patients, multimorbid (≥2 chronic conditions) or not, prescribed hypnotics/anxiolytics.DesignA longitudinal cohort studysettingPrimary healthcare in the Reykjavik ... -
Co-prescribing of opioids and benzodiazepines/Z-drugs associated with all-cause mortality—A population-based longitudinal study in primary care with weak opioids most commonly prescribed
Linnet, Kristjan; Thorsteinsdottir, Heidrun Sjofn; Sigurdsson, Johann Agust; Sigurdsson, Emil Larus; Gudmundsson, Larus Steinthor (Peer reviewed; Journal article, 2022)Introduction: The risk of mortality associated with the co-prescribing of benzodiazepines and opioids has been explored in a number of papers mainly focusing on strong opioids. The mortality risk associated with the use ... -
How primary healthcare in Iceland swiftly changed its strategy in response to the COVID-19 pandemic
Sigurdsson, Emil Larus; Blondal, Anna Bryndis; Jonsson, Jon Steinar; Tomasdottir, Margret Olafia; Hrafnkelsson, Hannes; Linnet, Kristjan; Sigurdsson, Johann Agust (Peer reviewed; Journal article, 2020)Objective To describe how the primary healthcare (PHC) in Iceland changed its strategy to handle the COVID-19 pandemic. Design Descriptive observational study. Setting Reykjavik, the capital of Iceland. Population ... -
Multimorbidity and use of hypnotic and anxiolytic drugs: Cross-sectional and follow-up study in primary healthcare in Iceland
Linnet, Kristjan; Gudmundsson, Larus J.; Birgisdottir, Frida G; Sigurdsson, Emil Larus; Jóhannsson, Magnús, Lyfjastofnun; Tomasdottir, Margret Olafia; Sigurdsson, Johann Agust (Peer reviewed; Journal article, 2016)Background The prevalence of multimorbidity is increasing worldwide, presumably leading to an increased use of medicines. During the last decades the use of hypnotic and anxiolytic benzodiazepine derivatives and related ...